A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method ...
[19] This study was limited by failure to establish the reliability of the bililabstix as a test for occult blood, failure to blind the test results, and retrospective patient classification.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback